Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack C Gur, Y Ibrahim, B Isaacson, R Yamin, J Abed, M Gamliel, J Enk, ... Immunity 42 (2), 344-355, 2015 | 1103 | 2015 |
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption JF Scheid, JA Horwitz, Y Bar-On, EF Kreider, CL Lu, JCC Lorenzi, ... Nature 535 (7613), 556-560, 2016 | 482 | 2016 |
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals Y Bar-On, H Gruell, T Schoofs, JA Pai, L Nogueira, AL Butler, K Millard, ... Nature medicine 24 (11), 1701-1707, 2018 | 232 | 2018 |
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller NT Freund, H Wang, L Scharf, L Nogueira, JA Horwitz, Y Bar-On, ... Science translational medicine 9 (373), eaal2144, 2017 | 170 | 2017 |
Non-neutralizing antibodies alter the course of HIV-1 infection in vivo JA Horwitz, Y Bar-On, CL Lu, D Fera, AAK Lockhart, JCC Lorenzi, ... Cell 170 (4), 637-648. e10, 2017 | 155 | 2017 |
Dynamic co-evolution of host and pathogen: HCMV downregulates the prevalent allele MICA∗ 008 to escape elimination by NK cells E Seidel, VTK Le, Y Bar-On, P Tsukerman, J Enk, R Yamin, N Stein, ... Cell reports 10 (6), 968-982, 2015 | 83 | 2015 |
Killing of avian and Swine influenza virus by natural killer cells H Achdout, T Meningher, S Hirsh, A Glasner, Y Bar-On, C Gur, A Porgador, ... Journal of virology 84 (8), 3993-4001, 2010 | 81 | 2010 |
Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells C Gur, S Coppenhagen-Glazer, S Rosenberg, R Yamin, J Enk, A Glasner, ... Cell host & microbe 14 (6), 664-674, 2013 | 78 | 2013 |
Elucidating the mechanisms of influenza virus recognition by Ncr1 A Glasner, A Zurunic, T Meningher, T Lenac Rovis, P Tsukerman, ... PloS one 7 (5), e36837, 2012 | 71 | 2012 |
Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors Y Bar-On, E Seidel, P Tsukerman, M Mandelboim, O Mandelboim The Journal of infectious diseases 210 (3), 410-418, 2014 | 55 | 2014 |
Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses Y Bar-On, A Glasner, T Meningher, H Achdout, C Gur, D Lankry, ... Cell reports 3 (4), 1044-1050, 2013 | 54 | 2013 |
The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity A Duev-Cohen, Y Bar-On, A Glasner, O Berhani, Y Ophir, F Levi-Schaffer, ... Oncotarget 7 (11), 13093, 2016 | 44 | 2016 |
Cytokine secretion and NK cell activity in human ADAM17 deficiency P Tsukerman, EM Eisenstein, M Chavkin, D Schmiedel, E Wong, ... Oncotarget 6 (42), 44151, 2015 | 43 | 2015 |
The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors R Yamin, NS Kaynan, A Glasner, A Vitenshtein, P Tsukerman, Y Bauman, ... PLoS pathogens 9 (8), e1003568, 2013 | 42 | 2013 |
Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III R Gruda, ACN Brown, V Grabovsky, S Mizrahi, C Gur, SW Feigelson, ... Blood, The Journal of the American Society of Hematology 120 (19), 3915-3924, 2012 | 27 | 2012 |
Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells MAG Hoffmann, Y Bar-On, Z Yang, HB Gristick, PNP Gnanapragasam, ... Proceedings of the National Academy of Sciences 117 (31), 18719-18728, 2020 | 25 | 2020 |
CEACAM1-mediated inhibition of virus production A Vitenshtein, Y Weisblum, S Hauka, A Halenius, E Oiknine-Djian, ... Cell reports 15 (11), 2331-2339, 2016 | 24 | 2016 |
Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses GHJ Weymar, Y Bar-On, TY Oliveira, C Gaebler, V Ramos, H Hartweger, ... Cell Reports 40 (10), 2022 | 23 | 2022 |
NK‐cell receptors NKp46 and NCR1 control human metapneumovirus infection M Diab, A Glasner, B Isaacson, Y Bar‐On, Y Drori, R Yamin, ... European journal of immunology 47 (4), 692-703, 2017 | 22 | 2017 |
NKp46 recognizes the sigma1 protein of reovirus: implications for reovirus-based cancer therapy Y Bar-On, Y Charpak-Amikam, A Glasner, B Isaacson, A Duev-Cohen, ... Journal of virology 91 (19), 10.1128/jvi. 01045-17, 2017 | 20 | 2017 |